Modular Medical shares rise 17.86% premarket after completing study of MODD1 Pump.

Modular Medical, Inc. rose 17.86% in premarket trading, with the company completing a study of its MODD1 Pump, a high-precision insulin pump designed for both type 1 and type 2 diabetes markets. The MODD1 Pump features a reusable and disposable part that snap together, a one-button interface, and a 90-day reusable, three-day disposable design, making it a convenient and user-friendly option for insulin delivery.